We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Sudden cramp

26 September 2019 By John Foley

The exercise-bike maker’s IPO valued it at $8 bln but its stock promptly sagged. The lack of profit is not the big problem. It’s the competition from other connected-workout startups and health fads plus dependence on a few key suppliers. That makes Peloton look anything but fit.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)